Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

618 Articles

Chris Lange | Apr 20, 2018 at 10:35 AM EDT

Will the FDA Shoot Down Eli Lilly and Incyte Again?

Incyte and Eli Lilly will be under the microscope next week as the FDA will decide the fate of their…

Jon C. Ogg | Apr 13, 2018 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: BBVA, Bed Bath & Beyond, Dropbox, Eli Lilly, Netflix, P&G, Splunk, Starbucks and More

The top analyst upgrades, downgrades and other research calls from Friday include BBVA, Bed Bath & Beyond, Dropbox, Eli Lilly,…

Chris Lange | Apr 11, 2018 at 8:30 AM EDT

The Major Pharma Stocks That Are Making Short Sellers Sick

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Mar 27, 2018 at 8:45 AM EDT

Which Major Pharma Stocks Short Sellers Are Keen On

The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Mar 12, 2018 at 8:35 AM EDT

Major Pharma Sees Big Drop in Short Interest

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Feb 28, 2018 at 9:10 AM EST

Short Sellers Hike Bets in Major Pharma

The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Feb 12, 2018 at 9:35 AM EST

Short Sellers Can’t Make Up Their Minds on Major Pharma

The January 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Lee Jackson | Feb 8, 2018 at 8:15 AM EST

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

Four large-cap pharmaceutical leaders are rated Overweight at JPMorgan, and all make sense for growth accounts looking for some safety…

Chris Lange | Jan 31, 2018 at 8:50 AM EST

Eli Lilly Cruises Through Q4 Earnings

Eli Lilly reported better-than-expected fourth-quarter financial results before the markets opened on Wednesday.

Chris Lange | Jan 25, 2018 at 10:10 AM EST

Major Pharma Short Interest Keeps Climbing

The January 12 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Jan 25, 2018 at 10:00 AM EST

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

With the market trading at very extended valuations, and the S&P 500 on the longest streak ever without a 5%…

Jon C. Ogg | Jan 22, 2018 at 9:14 AM EST

Top Analyst Upgrades and Downgrades: Apple, BHP Billiton, CBS, Eli Lilly, GE, Halliburton, IBM, Schlumberger, Verizon and More

The top analyst upgrades, downgrades and other research calls from Monday include Apple, BHP Billiton, CBS, Eli Lilly, GE, Halliburton,…

Jon C. Ogg | Jan 16, 2018 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Amazon, Boeing, Chesapeake Energy, Eli Lilly, Gilead, Micron, NVIDIA, P&G, Qualcomm and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Amazon.com, Boeing, Chesapeake Energy, Eli Lilly, Gilead Sciences,…

Chris Lange | Jan 11, 2018 at 9:45 AM EST

Major Pharma Short Interest Takes a Plunge

The December 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jan 6, 2018 at 8:55 AM EST

20 More Biopharma Catalysts Coming in 2018

Credit Suisse has put together a list of biopharma companies in its coverage universe that stand to make significant moves…

1 … 19 20 21 22 23 … 42

Eli Lilly : LLY

All Eli Lilly Articles

Will the FDA Shoot Down Eli Lilly and Incyte Again?

Top Analyst Upgrades and Downgrades: BBVA, Bed Bath & Beyond, Dropbox, Eli Lilly, Netflix, P&G, Splunk, Starbucks and More

The Major Pharma Stocks That Are Making Short Sellers Sick

Which Major Pharma Stocks Short Sellers Are Keen On

Major Pharma Sees Big Drop in Short Interest

Short Sellers Hike Bets in Major Pharma

Short Sellers Can’t Make Up Their Minds on Major Pharma

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

Eli Lilly Cruises Through Q4 Earnings

Major Pharma Short Interest Keeps Climbing

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

Top Analyst Upgrades and Downgrades: Apple, BHP Billiton, CBS, Eli Lilly, GE, Halliburton, IBM, Schlumberger, Verizon and More

Top Analyst Upgrades and Downgrades: Amazon, Boeing, Chesapeake Energy, Eli Lilly, Gilead, Micron, NVIDIA, P&G, Qualcomm and More

Major Pharma Short Interest Takes a Plunge

20 More Biopharma Catalysts Coming in 2018

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Eli Lilly : LLY

All Eli Lilly Articles

Will the FDA Shoot Down Eli Lilly and Incyte Again?

Top Analyst Upgrades and Downgrades: BBVA, Bed Bath & Beyond, Dropbox, Eli Lilly, Netflix, P&G, Splunk, Starbucks and More

The Major Pharma Stocks That Are Making Short Sellers Sick

Which Major Pharma Stocks Short Sellers Are Keen On

Major Pharma Sees Big Drop in Short Interest

Short Sellers Hike Bets in Major Pharma

Short Sellers Can’t Make Up Their Minds on Major Pharma

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

Eli Lilly Cruises Through Q4 Earnings

Major Pharma Short Interest Keeps Climbing

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

Top Analyst Upgrades and Downgrades: Apple, BHP Billiton, CBS, Eli Lilly, GE, Halliburton, IBM, Schlumberger, Verizon and More

Top Analyst Upgrades and Downgrades: Amazon, Boeing, Chesapeake Energy, Eli Lilly, Gilead, Micron, NVIDIA, P&G, Qualcomm and More

Major Pharma Short Interest Takes a Plunge

20 More Biopharma Catalysts Coming in 2018

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do